Biotechnology News

October 31, 2014

CAMBRIDGE, Mass. & STOCKHOLM--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application...

October 31, 2014

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation and Left Atrial Appendage Management, today announced that it will present at the Stifel Healthcare Conference...

October 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report third quarter 2014 financial results before the NASDAQ Global Market opens on Thursday, November 6, 2014....

October 31, 2014

NEW ORLEANS--(BUSINESS WIRE)--The New Orleans BioInnovation Center has announced the four finalists in the 3rd Annual BioChallenge — Louisiana’s only pitch competition for emerging life sciences startups.

October 31, 2014

MILWAUKEE--(BUSINESS WIRE)--Highlights of Recent Dohmen Life Science Services Summit, focused on reimagining the future of healthcare in light of the industry’s shifting paradigms and the rise of entrepreneurial innovations.

October 31, 2014

PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced today the publication of a peer-reviewed, independent study supporting the importance of mutational profiling in predicting the biologic...

October 31, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Sterigenics International LLC, a leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of GTCR, today announced it has acquired Gammarad, Italy’s...

October 31, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph...

October 31, 2014

MALVERN, Pa.--(BUSINESS WIRE)--Progenra, Inc. announced today that Dr. Wayne Hancock, Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine has joined their Scientific Advisory Board. Dr. Hancock is a world...

October 31, 2014

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) today reported financial results for the third quarter ended September 30, 2014. As of September 30, 2014, GlycoMimetics had cash and cash equivalents of $61.4 million, which...

October 31, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual...

October 31, 2014

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing management, economic, and financial consulting services, today announced that Ann Baker and Andrew Butcher have joined the firm as vice presidents...

October 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc. today announced two key additions to the company’s executive management team and board of directors.

October 31, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present...

October 31, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq: INSM), today announced that the Company will release financial results for the three month and nine months ended September 30, 2014, before the opening of the stock market on...

October 31, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today...

October 31, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a development pipeline of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced its financial results...

October 31, 2014

JERUSALEM--(BUSINESS WIRE)--BioLineRx Reports Publication in Peer Review Journal of Results from Previous Phase 1/2 Trial for BCM (BL-1040), a Novel Medical Device for Prevention of Cardiac Remodeling Following Acute Myocardial

October 31, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PROVECTUS BIOPHARMACEUTICALS, INC. TO HOLD QUARTERLY CONFERENCE CALL ON THURSDAY, NOVEMBER 6, 2014. Call Scheduled for 4 PM Eastern Standard Time.

October 31, 2014

MILAN--(BUSINESS WIRE)--Enrollment completed in the RESPOND CRT IDE Clinical Trial Using Innovative heart failure technology. Trial designed to demonstrate clinical benefits of SonR CRT optimization system.

October 31, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: -- 8 percent organic growth -- Adjusted EBITA has more than doubled during the first nine months of the year -- 57 percent of GHP’s revenues so far during 2014 stem from other sources of revenue...

October 31, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDA-A) has, in accordance with information previously announced, as part of the agreed purchase price for Rottapharm S.p.A., completed an issue of 30,000,000 series A shares in favor...

October 31, 2014

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Xcovery presents Phase 1 Results of X-396 in ALK positive NSCLC at the 2014 Multidisciplinary Symposium in Thoracic Oncology.

October 30, 2014

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. Announces Change in Management and Board of Directors

October 30, 2014

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-...

October 30, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that it will report its third quarter financial results on Thursday, November 13, 2014 after the close of the U.S. financial markets. At 4:30 p.m. ET, Retrophin’s management...

October 30, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the third quarter ended September 30, 2014, on Thursday, November 6, 2014 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The...

October 30, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the third quarter and nine months ended September 30, 2014. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization...

October 30, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported financial results for the quarter ended September 30, 2014. Revenues for...

October 30, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the third quarter ended September 28, 2014. The Company...

October 30, 2014

BOSTON--(BUSINESS WIRE)--Vertex to present at the Credit Suisse Healthcare Conference on November 11 at 12:00pm ET.

October 30, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) has scheduled a webcast of its upcoming Investor & Analyst Day on Wednesday, November 5, 2014, from 8:00 am to 12:00 pm Eastern Time. MDCO business and science leaders,...

October 30, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the third quarter of 2014. Results for the three months ended September 30, 2014: Total revenue was $87.1 million, compared to $80.4...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Nomura Biotechnology Conference on Thursday, November 6,...

October 30, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2014.

October 30, 2014

CHANDLER, Ariz.--(BUSINESS WIRE)--BCR Diagnostics unveils FiBIR, a novel optical technology for fluorescence amplification poised to revolutionize fluorescence-based assays by enabling the next generation of low-cost fluorometers.

October 30, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Cirrus Pharmaceuticals, a Kemwell company, to invest in
cGMP Manufacturing Suite in US.

October 30, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative biopharmaceutical company specializing in the development of orphan...

October 30, 2014

PARIS--(BUSINESS WIRE)--Event report: Individual Shareholders’ Meeting
held on October 23, 2014

October 30, 2014

NEW YORK & BASEL, Switzerland--(BUSINESS WIRE)--Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement

October 30, 2014

BERLIN--(BUSINESS WIRE)--EBS Technologies opens its second clinic, reports continuing efficacy using noninvasive electrical brain stimulation system designed to expand visual field of patients with impaired vision

October 30, 2014

SEATTLE--(BUSINESS WIRE)--H. Stewart Parker, a prominent leader in Seattle’s Biotechnology community, has joined Impel’s Board of Directors.

October 30, 2014

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Boston was the center of the biological development and manufacturing industry during IBC Life Sciences’ BioProcess International Conference & Exhibition held on October 21-23, 2014.

October 30, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation's eCOA System was chosen by 12 different pharmaceutical and biotech clients to collect patient-driven eData for 20 clinical research programs in 11 therapeutic areas in Q3 2014.

October 30, 2014

DOYLESTOWN, Pa.--(BUSINESS WIRE)--Marcum LLP and Philadelphia SmartCEO recognized the area’s top leaders in innovation at the 2014 Marcum Innovator of the Year Awards, which took place on October 22, 2014 at the Cescaphe Ballroom in Philadelphia...

October 30, 2014

BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) announces that three Johnson & Johnson Diabetes Solutions Companies have joined JITT as Founding Members and as members of JITT’s Advisory Board.

October 30, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment for PI at ESID in Prague.

October 30, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Phase 2 Objective Response Rate&Survival Data for Opdivo(nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at 2014 Chicago Multidisciplinary Symposium

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, announced today that it will hold a conference call and live audio...